Synthetic immunomodulation with a crispr super-repressor in vivo
An aptamer and amplicon technology applied in the field of synthetic immune regulation with CRISPR super-repressors in vivo
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0091] The embodiments described herein demonstrate the use of a CRISPR-based synthetic repression system to repress endogenous MyD88 expression in vitro and in vivo.
[0092]Embodiments described herein employ previously reported concepts of CRISPR versatility (see Dahlman, J.E. et al. "Orthogonal gene knockout and activation with a catalytically active Cas9nuclease," Nature biotechnology 33, 1159 (2015) and Kiani, S. et al. "Cas9 gRNAengineering for genome editing, activation and repression," Nature methods 12, 1051 (2015), each of which is incorporated herein by reference). The ability to switch between nuclease-dependent and -independent functions of a single Cas9 protein offers the exciting possibility of combining gene editing with epigenetic manipulation. The inventors previously reported that truncating a guide RNA (gRNA) from the 5' end enabled the application of nuclease-competent Cas9 protein for transcriptional regulation of genes. Liao et al. recently demonstrate...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com